BACKGROUND:

Chagas' disease is a zoonosis caused by a protozoan agent, Trypanosoma cruzi. patients undergoing immunosuppressive treatment due to organ transplant, malignancies, infections, or chemotherapy may reactivate a preexisting chronic or indeterminate Trypanosoma cruzi infection.

METHODS:

We present two transplant patients who underwent Reactivation of Chagas' disease with cutaneous manifestations after an augmentation in their immunosuppressive therapy. A 38-year-old man was hospitalized on day 69 after receiving an allogeneic bone marrow transplant; he developed multiple painful erythematous plaques with diffuse borders, confined to the right cheek, trunk, thigh, elbows, and feet. A 59-year-old woman with a 14-year history of Chagasic cardiomyopathy presented one month after heart transplantation with a painful infiltrated purpuric plaque on the back of her right leg.

RESULTS:

In both cases, histologic examination of skin biopsies showed dermal infiltration with intrahistiocytic amastigotes. In one of the reported cases, the Strout method detected parasitemia. Treatments with nifurtimox (600 mg/d) in case 1 and benznidazole (400 mg/d) in case 2 were started. Fever and cutaneous lesions resolved immediately after seven days of treatment.

CONCLUSIONS:

Reactivation of Chagas' disease is a serious complication that usually occurs in immunocompromised patients. Clinical manifestations include febrile illness occasionally associated with painful skin lesions. Early diagnosis and proper treatment can significantly improve these patients' outcome.

© 2012 The International Society of Dermatology.

Related Articles
Chagas' disease reactivation with skin symptoms in a patient with kidney transplant.
Int J Dermatol. 2007
Chagas' disease reactivation with skin symptoms in a patient with kidney transplant.
Gallerano V, Consigli J, Pereyra S, Gómez Zanni S, Danielo C, Gallerano RH, Guidi A. Int J Dermatol. 2007 Jun; 46(6):607-10.
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
J Heart Lung Transplant. 1998
Higher incidence of malignant neoplasms after heart transplantation for treatment of chronic Chagas' heart disease.
Bocchi EA, Higuchi ML, Vieira ML, Stolf N, Bellotti G, Fiorelli A, Uip D, Jatene A, Pileggi F. J Heart Lung Transplant. 1998 Apr; 17(4):399-405.
Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole.
Transpl Infect Dis. 1999
Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole.
Altclas J, Sinagra A, Jaimovich G, Salgueira C, Luna C, Requejo A, Milovic V, De Rissio A, Feldman L, Riarte A. Transpl Infect Dis. 1999 Jun; 1(2):135-7.
Review A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease.
J Card Fail. 2009
Review A systematic review of studies on heart transplantation for patients with end-stage Chagas' heart disease.
Bestetti RB, Theodoropoulos TA. J Card Fail. 2009 Apr; 15(3):249-55. Epub 2008 Dec 25.
Review Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature.
Clin Infect Dis. 1997
Review Reactivation of Chagas' disease in patients with AIDS: report of three new cases and review of the literature.
Ferreira MS, Nishioka Sde A, Silvestre MT, Borges AS, Nunes-Araújo FR, Rocha A. Clin Infect Dis. 1997 Dec; 25(6):1397-400.

To top • Home

---

Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer • webmaster